Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.60 | 43.10 |
| PEG Ratio (TTM) | -0.06 | 3.94 |
| P/S Ratio (TTM) | 5.93 | 4.16 |
| P/B Ratio (TTM) | 0.51 | 7.35 |
| P/FCF Ratio (TTM) | 45.87 | 68.80 |
| Price to 5YR AVG Earnings Ratio | -0.18 | 46.84 |
| Price to 5YR AVG FCF Ratio | -1.66 | 89.41 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.73% | 4.98% |
| ROE (TTM) | -9.95% | 19.06% |
| Net Profit Margin (TTM) | -87.93% | 2.40% |
| ROIC 5YR AVG | -13.67% | 9.50% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -311.70% | -33.38% | -21.84% |
| Revenue | 172.80% | 41.93% | 6.83% |
| Net Income | -340.50% | 69.23% | 65.95% |
| Cash Flow | 113.23% | -48.57% | 10.52% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.03 | 0.96 |
| Quick Ratio (TTM) | 0.03 | 0.91 |
| D/E Ratio (TTM) | 0.00 | 1.58 |
| Interest Coverage (TTM) | -20.97 | 6.46 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | N/A | 2.92 |
| LTL to 5YR AVG FCF | N/A | 28.74 |
| Shares Outstanding Growth 5YR AVG | 57.35% | 0.03% |